Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9401–9450 of 18437
OCG announces that Jay Wintrob’s service as chief executive officer of OCG will cease in the first quarter of 2024, when he will also cease to be a member of the board of directors of OCG.
Robert Carmichael, the Company’s Chairman, President and Chief Financial Officer, will assume the role of Chief Executive Officer on July 7, 2023.
On June 24, 2023, Christopher Constable submitted his resignation as Chief Executive Officer of Brownie’s Marine Group, Inc., a Florida corporation (the “Company”) effective July 7, 2023.
Faith Zaslavsky, age 48, has been appointed Chief Executive Officer of the Company effective June 26, 2023.
the Board appointed Parth Mehrotra, the Company’s current President and Chief Operating Officer, to succeed Mr. Morris as Chief Executive Officer of the Company effective July 1, 2023.
Shawn Morris notified the Board of Directors of the Company (the “Board”) that he would retire as Chief Executive Officer of the Company on July 1, 2023.
On June 27, 2023, the Board of Directors (the “Board”) of McCormick & Company, Incorporated (“McCormick”) appointed Brendan M. Foley as President and Chief Executive Officer of McCormick effective September 1, 2023.
Suzanne A. Scrabis has been appointed the Chief Financial Officer of the Company, effective July 10, 2023.
On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors
On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.
Michael Foliano, the former Senior Vice President of Finance and Chief Financial Officer of the Company, notified the Company of his intent to retire, effective June 28, 2023
The Board of Directors of Avalon Holdings Corporation (“Avalon”) approved the appointment of Michael J. Havalo as Chief Financial Officer and Treasurer effective June 26, 2023.
the Company received the resignation of Chris Brown as the Company’s President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary and Director
Mr. Meng resigned as Chairman, Chief Executive Officer and President of the Company and Mr. Su was appointed Chief Executive Officer and Chairman of the Company.
Mr. Meng resigned as Chairman, Chief Executive Officer and President of the Company and Mr. Su was appointed Chief Executive Officer and Chairman of the Company.
the Company also announced the appointment of Christophe Le Caillec as Chief Financial Officer of the Company, effective August 14, 2023.
On June 27, 2023, American Express Company (“American Express” or the “Company”) announced that Jeffrey C. Campbell will be retiring after a distinguished career with American Express and as a public company CFO.
Mr. David Viney, who was serving as the Company's Interim Chief Financial Officer in addition to his role as Vice President and Treasurer of the Company, will cease serving as Interim Chief Financial Officer upon the effectiveness of Mr. Root's appointment.
the Company announced the appointment of Jonathan Root as Chief Financial Officer of the Company, effective immediately.
Crispin Teufel, age 47, has been appointed to serve as the Chief Executive Officer of the Company, effective September 1, 2023.
the Board of Directors (the “Board”) of the Company had appointed Michael Andriole, age 50, to succeed Mr. Sherman as the Company’s President and Chief Executive Officer
Michael Sherman intends to retire as the Company’s President and Chief Executive Officer
Effective June 26, 2023, Harry L. You was appointed Chief Executive Officer and Chief Financial Officer of the Company.
(i) Jason Stein and Daniel Haimovic resigned as Co-Chief Executive Officers of the Company
(i) Jason Stein and Daniel Haimovic resigned as Co-Chief Executive Officers of the Company
(ii) Jason Beren resigned as the Company’s Chief Financial Officer
On June 23, 2023, the Board approved plans for Christian Gormsen, President, Chief Executive Officer, and member of the Board of Directors, to separate from the Company and to step down from his positions as President, Chief Executive Officer, and director, in each case, effective June 30, 2023.
On June 23, 2023, the Board appointed William Brownie as interim Chief Executive Officer of the Company to succeed Mr. Gormsen, effective June 30, 2023.
Andrew D. C. LaFrence has been employed by KORU Medical Systems, Inc. (the “Company”) to serve as its Chief Financial Officer commencing July 10, 2023.
Daniel J. Kimes and Rosemarie Cicalese, the Chief Executive Officer and Chief Financial Officer, respectively, of ROC, resigned.
Daniel J. Kimes and Rosemarie Cicalese, the Chief Executive Officer and Chief Financial Officer, respectively, of ROC, resigned.
On June 24, 2023, Jonathan Rowland informed the Board of Directors of the Registrant that he was resigning his positions as a director and as co-chief executive officer of the Registrant.
On June 24, 2023, the Board appointed Haywood Miller of Berkeley Research Group to serve as a non-employee interim Chief Executive Officer, effective immediately, until the Board’s search for a permanent Chief Executive Officer is completed.
On June 23, 2023, Robert G. Kramer Sr. notified the Board of Directors (the “Board”) of Emergent BioSolutions, Inc. (the “Company”) of his intent to retire from the Company on August 1, 2023 and to resign from his positions as President and Chief Executive Officer and as a director, effective June 24, 2023.
appointed Dr. Martin Brenner its then Interim Chief Executive Officer (CEO), to the position of permanent CEO effective immediately
On June 25, 2023, Elshad Garayev tendered his resignation as the Chief Financial Officer (principal financial and accounting officer) of the Company, with such resignation becoming effective on such date
On June 21, 2023, Hussein Rakine tendered his resignation as the Chief Executive Officer (principal executive officer) of Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (“ Flora ” or the Company ”), with such resignation becoming effective June 25, 2023
the Board of Directors of Agile Therapeutics, Inc. (the “Company”) appointed Scott Coiante to serve as Senior Vice President. Chief Financial Officer and Treasurer, effective August 16, 2023.
Edesa Biotech, Inc. (the “Company”) has appointed Stephen Lemieux (age 47) as our Chief Financial Officer pursuant to an employment agreement.
On June 22, 2023, Kathleen P. Leneghan informed Invacare Holdings Corporation (the “Company”) of her retirement from the Company, effective October 1, 2023.
Effective July 1, 2023, the Company has appointed Kai Zhu, the Company’s Vice President Finance EMEA, to serve as Senior Vice President and Chief Financial Officer of the Company.
Omnicell is now filing this Current Report on Form 8-K/A to report that Mr. Kuiper’s date of separation has been extended to August 1, 2023.
Mr. Gantt will retire from these positions effective June 30, 2023, but will remain a member of the Board.
In connection with Mr. Wong’s retirement, the Board appointed Mark Herrmann as the Company’s President and Chief Executive Officer, effective July 1, 2023.
On June 26, 2023, Mark Wong notified the Company of his decision to retire from his positions as an officer and/or employee of the Company and/or any of its subsidiaries, including as the Company’s President and Chief Executive Officer, effective as of July 1, 2023.
appointed Ned Preston, age 51, as Chief Financial Officer, effective June 26, 2023.
Paul Tarell resigned as Chief Financial Officer of Gaia, effective June 26, 2023.
The Company’s Board of Directors has decided to appoint Moran Shemesh Rojansky as the Company’s acting Chief Financial Officer, effective as of June 26, 2023 while a thorough search of internal and external candidates is conducted for a permanent replacement.
Anat Heller, Chief Financial Officer of Mobileye Global Inc. (the Company), will be stepping down as Chief Financial Officer effective as of June 26, 2023 for personal reasons.
Papa John’s International, Inc. (the "Company") announced the appointment of Ravi Thanawala as the Company’s Chief Financial Officer (CFO), effective July 24, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.